Thomas Gelzleichter

1.5k total citations
32 papers, 827 citations indexed

About

Thomas Gelzleichter is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Thomas Gelzleichter has authored 32 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Immunology and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Thomas Gelzleichter's work include Air Quality and Health Impacts (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Immunotherapy and Immune Responses (4 papers). Thomas Gelzleichter is often cited by papers focused on Air Quality and Health Impacts (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Immunotherapy and Immune Responses (4 papers). Thomas Gelzleichter collaborates with scholars based in United States, France and Switzerland. Thomas Gelzleichter's co-authors include Jerold A. Last, Hanspeter Witschi, Hanspeter Witschi, Iqbal S. Grewal, Rafael Ponce, Inge A. Ivens, Sean K. Kelley, Ferhan Qureshi, Barbara Mounho and Christopher Hurst and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Environmental Health Perspectives and The American Journal of Cardiology.

In The Last Decade

Thomas Gelzleichter

31 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Gelzleichter United States 17 304 253 205 141 119 32 827
Yoko Hirabayashi Japan 15 229 0.8× 331 1.3× 118 0.6× 166 1.2× 89 0.7× 57 942
J. M. G. Bonfrer Netherlands 14 103 0.3× 255 1.0× 129 0.6× 81 0.6× 27 0.2× 25 670
Serge M. Candéias France 22 876 2.9× 502 2.0× 308 1.5× 164 1.2× 99 0.8× 52 1.7k
Wilhelm Nothdurft Germany 16 97 0.3× 156 0.6× 238 1.2× 94 0.7× 27 0.2× 58 712
Kevin Hu United States 10 144 0.5× 385 1.5× 48 0.2× 76 0.5× 99 0.8× 22 948
Eugenia Colón Sweden 11 152 0.5× 199 0.8× 98 0.5× 39 0.3× 25 0.2× 17 717
Timothy M. Weiner United States 14 145 0.5× 328 1.3× 57 0.3× 127 0.9× 31 0.3× 23 1.0k
Mingyong Han China 20 120 0.4× 348 1.4× 132 0.6× 274 1.9× 26 0.2× 48 958
Monika Ortmann Germany 16 82 0.3× 221 0.9× 76 0.4× 125 0.9× 21 0.2× 50 648
Kerstin Müller Germany 15 149 0.5× 237 0.9× 215 1.0× 74 0.5× 15 0.1× 25 717

Countries citing papers authored by Thomas Gelzleichter

Since Specialization
Citations

This map shows the geographic impact of Thomas Gelzleichter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gelzleichter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gelzleichter more than expected).

Fields of papers citing papers by Thomas Gelzleichter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gelzleichter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gelzleichter. The network helps show where Thomas Gelzleichter may publish in the future.

Co-authorship network of co-authors of Thomas Gelzleichter

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gelzleichter. A scholar is included among the top collaborators of Thomas Gelzleichter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gelzleichter. Thomas Gelzleichter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ya‐Chi, Jiajie Yu, Ciara Metcalfe, et al.. (2021). Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer. Expert Opinion on Investigational Drugs. 31(6). 515–529. 48 indexed citations
2.
Pan, Lin, et al.. (2018). Effect of pirfenidone on gastric emptying in a rat model. Pulmonary Pharmacology & Therapeutics. 51. 41–47. 4 indexed citations
3.
4.
Mai, Elaine, Zhong Zheng, Youjun Chen, et al.. (2013). Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab. Molecular Cancer Therapeutics. 13(2). 540–552. 10 indexed citations
5.
Mortensen, Deborah L., Saileta Prabhu, Eric Stefanich, et al.. (2012). Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies. mAbs. 4(6). 724–731. 26 indexed citations
6.
Ponce, Rafael, Leslie W. Abad, Lakshmi Amaravadi, et al.. (2009). Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies. Regulatory Toxicology and Pharmacology. 54(2). 164–182. 179 indexed citations
7.
Kelley, Sean K., Thomas Gelzleichter, Dong Xie, et al.. (2007). Preclinical pharmacokinetics, pharmacodynamics and activity of a humanized anti‐CD40 antibody (SGN‐40) in rodents and non‐human primates. British Journal of Pharmacology. 150(2). 248–248. 45 indexed citations
8.
Vugmeyster, Yulia, Dhaya Seshasayee, Wesley Chang, et al.. (2006). A Soluble BAFF Antagonist, BR3-Fc, Decreases Peripheral Blood B Cells and Lymphoid Tissue Marginal Zone and Follicular B Cells in Cynomolgus Monkeys. American Journal Of Pathology. 168(2). 476–489. 60 indexed citations
9.
Kelley, Sean K., Thomas Gelzleichter, Dong Xie, et al.. (2006). Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti‐CD40 antibody (SGN‐40) in rodents and non‐human primates. British Journal of Pharmacology. 148(8). 1116–1123. 46 indexed citations
10.
Gelzleichter, Thomas, et al.. (1999). Protection against botulinum toxins provided by passive immunization with botulinum human immune globulin: evaluation using an inhalation model. Journal of Applied Toxicology. 19(S1). S35–S38. 27 indexed citations
11.
Everitt, Jeffrey I., Thomas Gelzleichter, Edilberto Bermudez, et al.. (1997). Comparison of Pleural Responses of Rats and Hamsters to Subchronic Inhalation of Refractory Ceramic Fibers. Environmental Health Perspectives. 105. 1209–1209. 2 indexed citations
12.
Everitt, Jeffrey I., Thomas Gelzleichter, Edilberto Bermudez, et al.. (1997). Comparison of pleural responses of rats and hamsters to subchronic inhalation of refractory ceramic fibers.. Environmental Health Perspectives. 105(suppl 5). 1209–1213. 13 indexed citations
13.
Gelzleichter, Thomas, et al.. (1996). Pulmonary and pleural leukocytes from F344 rats produce elevated levels of fibronectin following inhalation of refractory ceramic fibers. Experimental and Toxicologic Pathology. 48(6). 487–489. 1 indexed citations
14.
15.
Last, Jerold A., et al.. (1993). A New Model of Progressive Pulmonary Fibrosis in Rats. American Review of Respiratory Disease. 148(2). 487–494. 18 indexed citations
16.
Rajini, P.S., Thomas Gelzleichter, Jerold A. Last, & Hanspeter Witschi. (1993). Alveolar and Airway Cell Kinetics in the Lungs of Rats Exposed to Nitrogen Dioxide, Ozone, and a Combination of the Two Gases. Toxicology and Applied Pharmacology. 121(2). 186–192. 17 indexed citations
17.
Gelzleichter, Thomas, Hanspeter Witschi, & Jerold A. Last. (1992). Synergistic interaction of nitrogen dioxide and ozone on rat lungs: Acute responses. Toxicology and Applied Pharmacology. 116(1). 1–9. 23 indexed citations
18.
Gelzleichter, Thomas, Hanspeter Witschi, & Jerold A. Last. (1992). Concentration-response relationships of rat lungs to exposure to oxidant air pollutants: A critical test of Haber's Law for ozone and nitrogen dioxide. Toxicology and Applied Pharmacology. 112(1). 73–80. 47 indexed citations
19.
Last, Jerold A., et al.. (1990). Particle-Cell Interactions: Lung Fibrogenesis. Journal of Aerosol Medicine. 3(s1). S–61. 4 indexed citations
20.
Last, Jerold A., Joan E. Gerriets, Lucas C. Armstrong, Thomas Gelzleichter, & Karen M. Reiser. (1990). Hydroxylation of Collagen by Lungs of Rats Administered Bleomycin. American Journal of Respiratory Cell and Molecular Biology. 2(6). 543–548. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoko Hirabayashi Breakdown of academic impact, for papers by J. M. G. Bonfrer Breakdown of academic impact, for papers by Serge M. Candéias Breakdown of academic impact, for papers by Wilhelm Nothdurft Breakdown of academic impact, for papers by Kevin Hu Breakdown of academic impact, for papers by Eugenia Colón Breakdown of academic impact, for papers by Timothy M. Weiner Breakdown of academic impact, for papers by Mingyong Han Breakdown of academic impact, for papers by Monika Ortmann Breakdown of academic impact, for papers by Kerstin Müller
Rankless by CCL
2026